Home / Levodopa, Decarboxylase Inhibitor and COMT Inhibitor / Spain
ES ATC N04BA03 · updated 2 Nov 2026
Levodopa, Decarboxylase Inhibitor and COMT Inhibitor shortage in Spain
Is there a Levodopa, Decarboxylase Inhibitor and COMT Inhibitor shortage in Spain?
Yes. As of 2 Nov 2026, 2 Levodopa, Decarboxylase Inhibitor and COMT Inhibitor products are reported short in Spain, the first since 8 Oct 2026. The company estimate for the return is 26 Nov 2026 (latest 2 Dec 2026). Main reason: not stated.
Also short in Italy, Czechia, Sweden. All countries.
Affected products in Spain
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| ES | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 100 MG/25 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos | Laboratorios Cinfa S.A. | 8 Oct 2026 | 26 Nov 2026 | Not stated |
| ES | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 100 mg/25 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 100 comprimidos | Kern Pharma S.L. | 8 Oct 2026 | 2 Dec 2026 | Not stated |
Source
AEMPS (Spanish Agency of Medicines and Medical Devices), CIMA. Official list. All authorised presentations with a declared supply problem.